Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus

References

• Mozaffarian D, Benjamin EJ, Go AS, et al.; for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics – 2016 Update: A report from the American Heart Association. Circulation 2016;133:e38-e360
   PubMed Web of Science ®Google Scholar
• Bailey RA, Wang Y, Zhu V, Rupnow MF. Chronic kidney disease in US adults with type 2 diabetes: An updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging. BMC Res Notes 2014;7:415
   PubMedGoogle Scholar
• Lin PJ, Kent DM, Winn A, et al. Multiple chronic conditions in type 2 diabetes mellitus: Prevalence and consequences. Am J Manag Care 2015;21:e23-34
   PubMed Web of Science ®Google Scholar
• Piette J, Kerr E. The impact of comorbid chronic conditions on diabetes care. Diabetes Care 2006;29:725-30
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes – 2016. Diabetes Care 2016;39(Suppl 1):S1-S112
   PubMed Web of Science ®Google Scholar
• Monami M, Genovese S, Mannucci E. Cardiovascular safety of sulfonylureas: A meta-analysis of randomized clinical trials. Diabetes Obes Metab 2013;15:938-53
   PubMed Web of Science ®Google Scholar
• Phung OJ, Schwartzman E, Allen RW, et al. Sulphonylureas and risk of cardiovascular disease: Systematic review and meta-analysis. Diabet Med 2013;30:1160-71
   PubMed Web of Science ®Google Scholar
• Scirica BM, Braunwald E, Raz I, et al. Heart failure, saxagliptin, and diabetes mellitus: Observations from the SAVOR-TIMI 53 randomized trial. Circulation 2014;130:1579-88
   PubMed Web of Science ®Google Scholar
• White WB, Cannon CP, Heller SR, et al.; for the EXAMINE Investigators. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med 2013;369:1327-35
   PubMed Web of Science ®Google Scholar
• Green JB, Bethel MA, Armstrong PW, et al.; for the TECOS Study Group. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med 2015;373:232-42
   PubMed Web of Science ®Google Scholar
• Salvo MC, Brooks AD, Thacker SM. Patient considerations in the management of type 2 diabetes – critical appraisal of dapagliflozin. Patient Pref Adh 2014;8:493-502
   PubMed Web of Science ®Google Scholar
• Zinman B, Wanner C, Lachin J, et al. Empagliflozin, cardiovascular outcomes and mortality in type 2 diabetes. N Engl J Med 2015;373:2117-28
   PubMed Web of Science ®Google Scholar
• Ginde AA, Blanc PG, Lieberman RM, Camargo CA Jr. Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits. BMC Endocr Disord 2008;8:4
   PubMedGoogle Scholar
• Teljeur C, Smith SM, Paul G, et al. Multimorbidity in a cohort of patients with type 2 diabetes. Eur J Gen Pract;19:17-22
   PubMed Web of Science ®Google Scholar
• Caughey GE, Roughead EE, Vitry AI, et al. Comorbidity in the elderly with diabetes: identification of areas of potential treatment conflicts 2010;87:385-93
   Google Scholar
• Alonso-Morán E, Orueta JF, Fraile Esteban JI, et al. The prevalence of diabetes-related complications and multimorbidity in the population with type 2 diabetes mellitus in the Basque Country. BMC Public Health 2014;14:1059
   PubMed Web of Science ®Google Scholar
• Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988–1994 and 1999–2010. Ann Intern Med 2014;160:517-25
   PubMed Web of Science ®Google Scholar
• Yoon J, Zulman D, Scott JY, Maciejewski ML. Costs associated with multimorbidity among VA patients. Med Care 2014;52(Suppl 3):S31-S6
   PubMed Web of Science ®Google Scholar
• Fortin M, Bravo G, Hudon C, et al. Psychological distress and multimorbidity in primary care. Ann Fam Med 2006;4:417-22
   PubMed Web of Science ®Google Scholar
• Fortin M, Lapointe L, Hudon C, et al. Multimorbidity and quality of life in primary care: A systematic review. Health Qual Life Outcomes 2004;2:51
   PubMedGoogle Scholar
• Gunn JM, Ayton DR, Densley K, et al. The association between chronic illness, multimorbidity and depressive symptoms in an Australian primary care cohort. Soc Psychiatry Psychiatr Epidemiol 2012;47:175-84
   PubMed Web of Science ®Google Scholar
• France EF, Wyke S, Gunn JM, et al. Multimorbidity in primary care: A systematic review of prospective cohort studies. Br J Gen Pract 2012;62:e297-307
   PubMed Web of Science ®Google Scholar
• Grembowski D, Paschane D, Diehr P, et al. Managed care, physician job satisfaction, and the quality of primary care. J Gen Intern Med 2005;20:271-7
   PubMed Web of Science ®Google Scholar
• Dugdale DC, Epstein R, Pantilat SZ. Time and the patient-physician relationship (Review). J Gen Intern Med 1999;14(Suppl 1):S34-S40
   PubMedGoogle Scholar
• Wallace E, Salisbury C, Guthrie B, et al. Managing patients with multimorbidity in primary care. BMJ 2015;350:h176
   PubMed Web of Science ®Google Scholar
• Stark Casagrande S, Fradkin JE, Saydah SH, et al. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care 2013;36:2271-9
   PubMed Web of Science ®Google Scholar
• Pentakota SR, Rajan M, Fincke BG, et al. Does diabetes care differ by type of chronic comorbidity? An evaluation of the Piette and Kerr framework. Diabetes Care 2012;35:1285-92
   PubMed Web of Science ®Google Scholar
• Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002;162:2269-76
   PubMed Web of Science ®Google Scholar
• Struijs JN, Baan CA, Schellevis FG, et al. Comorbidity in patients with diabetes mellitus: Impact on medical health care utilization. BMC Health Serv Res 2006;6:84
   PubMed Web of Science ®Google Scholar
• Sambamoorthi U, Tan X, Deb A. Multiple chronic conditions and healthcare costs among adults. Expert Rev Pharmacoecon Outcomes Res 2015;15:823-32
   PubMed Web of Science ®Google Scholar
• Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 2010;304:649-56
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556-64
   PubMed Web of Science ®Google Scholar
• Klein R, Lee KE, Gangnon RE, Klein BE. The 25-year incidence of visual impairment in type 1 diabetes mellitus the Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology 2010;117:63-70
   PubMed Web of Science ®Google Scholar